Pentoxifylline

Chemical formula: C₁₃H₁₈N₄O₃  Molecular mass: 278.307 g/mol  PubChem compound: 4740

Therapeutic indications

Pentoxifylline is indicated for:

Peripheral vascular disease, intermittent claudication, rest pain

Population group: only adults (18 years old or older)

Pentoxifylline is indicated in the treatment of peripheral vascular disease, including intermittent claudication and rest pain.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pentoxifylline is contraindicated in the following cases:

Acute myocardial infarction

Acute myocardial infarction

Hypersensitivity to pentoxifylline

Oxpentifylline allergy

Cerebral haemorrhage

Cerebral hemorrhage

Retinal haemorrhage

Retinal hemorrhage

Severe cardiac arrhythmias

Arrhythmia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: TRENTAL 400 Modified release tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈